Production (Stage)
CalciMedica, Inc.
CALC
$1.70
-$0.02-1.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -19.48% | 52.31% | 6.26% | -14.34% | -10.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.66% | 42.90% | 18.68% | -0.82% | -6.07% |
| Operating Income | -12.66% | -42.90% | -18.68% | 0.82% | 6.07% |
| Income Before Tax | -3,978.46% | -2.70% | -21.63% | 37.28% | 100.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3,978.46% | -2.70% | -21.63% | 37.28% | 100.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3,978.46% | -2.70% | -21.63% | 37.28% | 100.67% |
| EBIT | -12.66% | -42.90% | -18.68% | 0.82% | 6.07% |
| EBITDA | -12.69% | -43.21% | -18.67% | 0.82% | 6.12% |
| EPS Basic | -2,784.21% | 54.53% | 38.10% | 68.09% | 100.06% |
| Normalized Basic EPS | -2,789.16% | 54.53% | 38.10% | 68.08% | 100.35% |
| EPS Diluted | -3,700.00% | 54.53% | 38.10% | 68.09% | 100.06% |
| Normalized Diluted EPS | -2,855.56% | 54.53% | 38.10% | 68.08% | 100.35% |
| Average Basic Shares Outstanding | 44.77% | 125.81% | 96.48% | 96.56% | 1,085.09% |
| Average Diluted Shares Outstanding | 40.55% | 125.81% | 96.48% | 96.56% | 1,120.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |